tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Chimeric Therapeutics Announces Change in Substantial Holder Interests

Story Highlights
Chimeric Therapeutics Announces Change in Substantial Holder Interests

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Chimeric Therapeutics Ltd. ( (AU:CHM) ) has shared an update.

Chimeric Therapeutics Ltd. has announced a change in the interests of its substantial holder, Paul Hopper, as of July 25, 2025. The voting power associated with fully paid ordinary shares has decreased from 10.2% to 6.3%, indicating a significant shift in shareholder influence. This change may impact the company’s governance and decision-making processes, potentially affecting its strategic direction and stakeholder relationships.

More about Chimeric Therapeutics Ltd.

Chimeric Therapeutics Ltd. operates in the biotechnology industry, focusing on the development of innovative cell therapies. The company is primarily engaged in creating advanced treatments for cancer, leveraging cutting-edge research and technology to improve patient outcomes.

Technical Sentiment Signal: Sell

Current Market Cap: A$9.75M

For detailed information about CHM stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1